|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/16 | (2006.01) |
| A61K 9/1676 | (2013.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61K 9/4808 | (2013.01) | ||
| A61K 31/00 | (2006.01) | ||
| A61K 9/2013 | (2013.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 31/53 | (2013.01) |
| (11) | Number of the document | 4069199 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20819676.6 |
| Date of filing the European patent application | 2020-12-01 | |
| (97) | Date of publication of the European application | 2022-10-12 |
| (45) | Date of publication and mention of the grant of the patent | 2024-01-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2020/084160 |
| Date | 2020-12-01 |
| (87) | Number | WO 2021/110697 |
| Date | 2021-06-10 |
| (30) | Number | Date | Country code |
| 201962942417 P | 2019-12-02 | US |
| (72) |
HOLMGREN, Anders , SE
KYSSÄ, Annika , SE
VON CORSWANT, Christian , SE
SKANTZE, Urban , SE
|
| (73) |
Astrazeneca AB ,
151 85 Södertälje,
SE
|
| (54) | SOLID PHARMACEUTICAL FORMULATIONS OF 6-(2-CHLORO-6-METHYLPYRIDIN-4-YL)-5-(4-FLUOROPHENYL)-1,2,4-TRIAZIN-3-AMINE |
| SOLID PHARMACEUTICAL FORMULATIONS OF 6-(2-CHLORO-6-METHYLPYRIDIN-4-YL)-5-(4-FLUOROPHENYL)-1,2,4-TRIAZIN-3-AMINE |